EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Characterization of Alagille Syndrome in Patients with Cholestatic Liver Disease

Natalia Semenova iD, Elena Kamenets iD, Eleonora Annenkova, Andrey Marakhonov iD, Elena Gusarova, Nina Demina, Daria Guseva, Inga Anisimova, Anna Degtyareva iD, Natalia Taran, Tatiana Strokova, Ekaterina Zakharova

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241411758 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Natalia Semenova und 11 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for Medical Genetics, 115522 Moscow, Russia. Hauptthemen laut MEDLINE: Alagille Syndrome, Cholestasis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alagille syndrome (ALGS) is a multisystem condition characterized by cholestasis and bile duct paucity on liver biopsy and variable involvement of the heart, skeleton, eyes, kidneys, and face and caused by pathogenic variants in the JAG1 or NOTCH2 gene. The variable expressivity of the clinical phenotype and the lack of genotype–phenotype correlations lead to significant diagnostic difficulties. Here we present an analysis of 18 patients with cholestasis who were diagnosed with ALGS. We used an NGS panel targeting coding exons of 52 genes, including the JAG1 and NOTCH2 genes. Sanger sequencing was used to verify the mutation in the affected individuals and family members. The specific facial phenotype was seen in 16/18 (88.9%). Heart defects were seen in 8/18 (44.4%) patients (pulmonary stenosis in 7/8). Butterfly vertebrae were seen in 5/14 (35.7%) patients. Renal involvement was detected in 2/18 (11.1%) cases—one patient had renal cysts, and one had obstructive hydronephrosis. An ophthalmology examination was performed on 12 children, and only one had posterior embryotoxon (8.3%). A percutaneous liver biopsy was performed in nine cases. Bile duct paucity was detected in six/nine cases (66.7%). Two patients required liver transplantation because of cirrhosis. We identified nine novel variants in the JAG1 gene—eight frameshift variants (c.1619_1622dupGCTA (p.Tyr541X), c.1160delG (p.Gly387fs), c.964dupT (p.C322fs), c.120delG (p.L40fs), c.1984dupG (p.Ala662Glyfs), c.3168_3169delAG (p.R1056Sfs*51), c.2688delG (p.896CysfsTer49), c.164dupG (p.Cys55fs)) and one missense variant, c.2806T > G (p.Cys936Gly). None of the patients presented with NOTCH2 variants. In accordance with the classical criteria, only six patients could meet the diagnostic criteria in our cohort without genetic analysis. Genetic testing is important in the diagnosis of ALGS and can help differentiate it from other types of cholestasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alagille SyndromeCholestasisHumansMutationMutation, MissensePhenotypeJagged-1 Protein

Stichwörter der Autor:innen

Alagille syndromeJAG1 genebiochemical characteristicscholestasis

Substanzen

Jagged-1 Protein

Autor:innen und Institutionen

  • Research Centre for Medical Genetics, 115522 Moscow, Russia.
  • National Medical Research Center for Obstetrics, Gynecology and Perinatology named after V.I. Kulakov, Ministry of Health of the Russian Federation, 115522 Moscow, Russia.
  • Department of Neonatology, First Moscow State Medical University named after I.M. Sechenov, 115522 Moscow, Russia.
  • Federal Research Centre of Nutrition and Biotechnology, 115522 Moscow, Russia.

ORCID-Profile: Natalia Semenova, Elena Kamenets, Andrey Marakhonov, Anna Degtyareva

Förderung

  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Semenova, N., Kamenets, E., Annenkova, E., Marakhonov, A., Gusarova, E., Demina, N., Guseva, D., Anisimova, I., Degtyareva, A., Taran, N., Strokova, T., & Zakharova, E. (2023). Clinical Characterization of Alagille Syndrome in Patients with Cholestatic Liver Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241411758

Vancouver

Semenova N, Kamenets E, Annenkova E, Marakhonov A, Gusarova E, Demina N, et al. Clinical Characterization of Alagille Syndrome in Patients with Cholestatic Liver Disease. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241411758

BibTeX
@article{Semenova2023,
  author = {Semenova, Natalia and Kamenets, Elena and Annenkova, Eleonora and Marakhonov, Andrey and Gusarova, Elena and Demina, Nina and Guseva, Daria and Anisimova, Inga and Degtyareva, Anna and Taran, Natalia and Strokova, Tatiana and Zakharova, Ekaterina},
  title = {Clinical Characterization of Alagille Syndrome in Patients with Cholestatic Liver Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241411758}
}
Kostenlos starten →